Northglenn Heights Assisted Living Community

A licensure complaint prompted by #CO38531, #CO38797, #CO38801, #CO39022, #CO39301, #CO39633, and #CO40990 was completed on 10/24/25. A deficiency was cited. A change of ownership occurred on 8/18/25. Based on interviews and record reviews, the residence failed to comply with authorized practitioner' s orders associated with medication administration, affecting three of five sample residents (#1, #6 and #7) whose medications were reviewed.Findings include:1. Record ReviewResident #6 was admitted to the residence on 3/26/2025 with a diagnosis including atrial fibrillation.a. Metoprolol Succinate Extended Release 25mgA practitioner ' s order, dated 6/11/25, directed the residence to administer 25mg of metoprolol succinate by mouth daily to Resident #6. The September 2025 medication administration record (MAR) showed a "9 code" for the scheduled medication dose on 9/3/25, that indicated the medication was missing and not administered to Resident #6.b. Risperidone 0.25mgA practitioner' s order, dated 6/11/25, directed the residence to administer 0.25mg of risperidone by mouth every evening to Resident #6. The September 2025 MAR showed a "9 code" for the scheduled dose on 9/4/25 that indicated the medication was missing and not administered to Resident #6.c. Eliquis 2.5mgA practitioner' s order, dated 6/11/25, directed the residence to administer 0.25mg of Eliquis by mouth twice daily to Resident #6. The September 2025 MAR showed a "9 code" for the scheduled dose on 9/4/25 that indicated the medication was missing and not administered to Resident #6.d. Levothyroxine 100mcgA practitioner' s order, dated 6/11/25, directed the residence to administer 100mcg of levothyroxine by mouth daily to Resident #6. The September 2025 MAR showed a "9 code" for the scheduled dose on 9/15/25 that indicated the medication was missing and not administered to Resident #6. The October 2025 MAR also showed a "9 code" for the scheduled dose on 10/7/25, indicating the medication was missing and not administered to Resident #6.e. Losartan Potassium 25mgA practitioner' s order, dated 6/11/25, directed the residence to administer half a tablet of 25mg losartan potassium by mouth daily to Resident #6. The September 2025 MAR show..

A licensure complaint, prompted by #CO40399 was completed on 6/17/25. A deficiency was cited. Based on observation, record review, and interview, the residence failed to either directly or indirectly, through a resident agreement, provide protective oversight and a physically safe and sanitary environment, affecting four sample residents ( #64, #67, #68, and #72).Findings Include:1. Residence PolicyThe residence' s Resident Agreement, read, in part, "Apartment condition. The resident shall maintain the apartment in a clean and sanitary condition at all times."2. ObservationOn 6/17/25 at 8:15 a.m., a pronounced, damp, musky odor was observed in Resident #68' s room that protruded to the hallway. The resident' s personal belongings had been stacked in piles or relegated to the corners, resulting in limited mobility, as he could only navigate in a linear path from his desk to the patio door and into the bedroom and bathroom. The carpet had various shades of grey and black. A hand towel was laid flat on the carpet on one of the walking paths. 3. InterviewOn 6/17/25 at 12:12 p.m., the administrator acknowledged the strong smell of the unsafe and unsanitary conditions in Resident #68' s room. She stated that the resident had resided at the residence for approximately six years. She stated that family and Resident #68 had been in denial about the living conditions and that she had planned to make an appointment with family members and an outside source to discuss this situation. 4. Similar deficient practice was found for Resident #64, #67, and #72 whose rooms were either cluttered, unsafe and unsanitary due to unidentified stains on carpets, duck tape on floors holding carpet together, and dog urine and feces on disposable pads on a living room floor.